Supply Chain

An analysis by Sen. Cory Booker, D-N.J., suggests the nation's largest pharmaceutical companies do not plan to use new tax savings to lower prescription drug prices for consumers.

The generic drug industry, which supplies about 86 percent of the drugs prescribed in the U.S., is in a financial crisis — causing manufactures themselves to question the viability of the business, according to Bloomberg.  

With 83 percent of Americans worrying about the rising price of prescriptions, CVS Health will roll out a comprehensive tool that alerts pharmacists to cheaper drug options when they fill patients' prescriptions in an effort to reign in drug costs.

The FDA on April 11 approved IDx to market IDx-DR, a medical device that uses artificial intelligence to detect diabetic retinopathy.

A woman said she discovered a used medical device in the middle of Jacksonville, Fla.-based Baptist Medical Center South's parking lot April 9, according to News4Jax.

The FDA on Tuesday cleared Acuvue Oasys contact lenses with transitions light intelligent technology as the first contact lens to automatically darken amid bright light exposure.

The FDA on April 9 restricted the sale and distribution of Bayer's permanent birth control device Essure to ensure women are well-informed of the device's risks before choosing the contraceptive method.

In addition to chemotherapies for leukemia and antidepressants for schizophrenia, among other medications, Japanese drug manufacturer Otsuka owns a vineyard in Northern California. The reason? The drugmaker's chairman at the time loved a good Bordeaux, according to STAT News.

Novartis will pay $218 per share for AveXis, a $8.7 billion deal that is a 72 percent premium to the company's 30-day volume-weighted average stock price, according to Reuters.

A historic teacher strike in Oklahoma may hurt the state's blood supply, since 20 percent of blood donations come from high school blood drives, reports KTUL.